Measles is a viral disease of childhood that presents with a rash and fever (often with initial cough and cold symptoms).
It can cause significant illness in children, and complications include ear infections, pneumonia, meningitis and encephalitis. Death occurs in 1 in 2,500-5,000 cases. A severe degenerative condition of the brain (sub-acute sclerosing pan-encephalitis) causing permanent severe brain damage occurs in 1 in 8,000 cases under the age of 2.
Measles can be prevented by MMR single vaccination. MMR single vaccination is a safe alternative to the NHS MMR schedule. Single MMR jabs are given at six week intervals. We recommend that either Rubella single MMR jab or the measles single MMR jab is given first. We suggest that the Mumps single MMR jab is left to the end of each course (single Mumps is currently not available), as this single MMR jab is often more irritant to the child.
Two courses of single MMR jabs are required for permanent immunity: the first single MMR course is given between 13-18 months, the second “booster” course is given at 3 ½ years onwards (the “pre-school” single MMR vaccination).
This single MMR vaccination schedule is identical to that recommended by the NHS, apart from using single jabs as opposed to the NHS combined MMR vaccine.
MMR single vaccinations are manufactured in France and India. All MMR single vaccinations are approved by the World Health Organisation (WHO), and MMR single vaccinations have a specific import licence granted by the Medicines Health Regulatory Agency (MHRA), the body that maintains strict control on the use of medicines and vaccines in the UK.
MMR single jabs are specially imported and stored at temperatures between 2-8 C., to ensure that their effectiveness is maintained.